Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 15/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 8/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 14/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 14/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 7/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 7/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 7/20 | 0.34 |
| ▸ | HDAC10 | Q969S8 | 7/20 | 0.34 |
| ▸ | HDAC11 | Q96DB2 | 7/20 | 0.34 |
| ▸ | HDAC9 | Q9UKV0 | 7/20 | 0.34 |
| ▸ | HDAC5 | Q9UQL6 | 7/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.30 |
| ▸ | ITGAV | P06756 | 2/20 | 0.30 |
| ▸ | ITGB5 | P18084 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31682827 | 0.93 | ELANE (0.36) | ELANEHDAC6HDAC8HDAC3HDAC1 | |
| SCHEMBL22561402 | 0.88 | ELANE (0.35) | ELANEHDAC6HDAC8HDAC3HDAC1 | |
| SCHEMBL29293293 | 0.88 | ELANE (0.38) | ELANEHDAC6HDAC3HDAC1HDAC2 | |
| SCHEMBL23193211 | 0.87 | ELANE (0.34) | ELANEHDAC6HDAC8HDAC3HDAC1 | |
| SCHEMBL27410362 | 0.87 | HDAC6 (0.34) | ELANEHDAC6HDAC8HDAC3HDAC1 | |
| SCHEMBL21138197 | 0.85 | ELANE (0.37) | ELANEHDAC6HDAC8HDAC3HDAC1 | |
| SCHEMBL22618829 | 0.85 | ELANE (0.35) | ELANEHDAC6HDAC8HDAC3HDAC1 | |
| SCHEMBL22561323 | 0.85 | ELANE (0.35) | ELANEHDAC6HDAC8HDAC3HDAC1 | |
| SCHEMBL22561273 | 0.84 | ELANE (0.35) | ELANEHDAC6HDAC8HDAC3HDAC1 | |
| SCHEMBL23193147 | 0.84 | ELANE (0.34) | ELANEHDAC6HDAC8HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250281631-A1 | ANTIBODY-DRUG CONJUGATES AND PREPARATION METHODS AND USE THEREOF | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2025-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250281631-A1 | ANTIBODY-DRUG CONJUGATES AND PREPARATION METHODS AND USE THEREOF | TOP1, TOP2A, TOP2B | ELANE 2611/4885HDAC6 923/4885HDAC8 869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.